Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation.

Respiratory syncytial virus (RSV) pneumonia in marrow transplant recipients is associated with significant mortality. Ribavirin is a nucleoside analog with activity against RSV and in its aerosolized formulation is the only drug approved for treatment of RSV pneumonia in the United States. The clini...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

-д хэвлэсэн:	Antimicrob Agents Chemother
Үндсэн зохиолчид:	Lewinsohn, D M, Bowden, R A, Mattson, D, Crawford, S W
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	American Society for Microbiology (ASM) 1996
Нөхцлүүд:	Research Article
Онлайн хандалт:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163574/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8913463/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.11.2555
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!